TSX: HSM     OTC: HSDT

Call us: +1 215-809-2018

people2

President, Chief Executive Officer and Chairman of the Board of Directors

Phil joined Helius Medical Technologies in 2013. He has more than 28 years of experience in pharmaceutical and healthcare commercialization gained at Bristol Myers Squibb (BMS) and as CEO of GSW Worldwide and, later, at MediMedia Health.

Before joining Helius, Phil led MediMedia Health Marketing Services, where he was responsible for strategic development, nurturing the company’s clients and developing nonpersonal products and services in the healthcare industry.

As GSW’s president and CEO, Phil was responsible for worldwide operations in 15 major global markets and a turnover of $160 million with 700 employees globally. His primary work included global marketing, commercialization and new business model development for pharmaceutical, device and diagnostics companies.

Phil’s role as director of neuroscience marketing at BMS saw him serve as a member of several prelaunch global marketing teams in the neuroscience and pain therapeutic areas. He also held marketing positions in the neuroscience, pain, and metabolic therapeutic areas.

He is a leader in developing new global business models for the healthcare industry, including outsourcing solutions that seek to increase commercialization effectiveness and increase resource flexibility while reducing risk and driving efficiency and cost reduction. His experience as a global healthcare commercialization expert will guide Helius in its development and acquisition of noninvasive treatments designed to help patients affected by neurological symptoms caused by disease or trauma. Watch the “CEO Clips” interview with Phil about the growth of Helius and the PoNS technology.

Phil graduated from the University of Ottawa with a degree in Chemistry. He is fluent in French and English. He resides in Newtown, PA, with his wife Nicole and two children.